GL1X · GenesisL1 explorer

MolNFT v1 · #37274 · protein

Crystal structure of rat carnitine palmitoyltransferase 2 in complex with antidiabetic drug ST1326

2FW3 · Carnitine O-palmitoyltransferase II, mitochondrial: “Crystal structure of rat carnitine palmitoyltransferase 2 in complex with antidiabetic drug ST1326”. X-ray diffraction, 1 ligand (BUI), 5 pockets (best druggability 0.81). MolNFT…

PDB
2FW3
Type
protein
Length
623 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carnitine O-palmitoyltransferase II, mitochondrial
EC
2.3.1.21
UniProt
P18886
Ligands
BUI
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)protein62347% helix, 14% strandP18886

Ligands and binding sites

  • BUI · (3R)-3-{[(tetradecylamino)carbonyl]amino}-4-(trimethylammonio)butanoate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19450.810.8296BUI
2640.590.9019empty
3500.420.8316empty
4590.380.8016empty
5570.320.7613empty

Compared structures

  • 2FW3 · Crystal structure of rat carnitine palmitoyltransferase 2 in complex with antidiabetic… · the same entry in another collection · chain A against A, TM-score 1.00
  • P18886 · AlphaFold monomer V2.0 prediction for carnitine O-palmitoyltransferase 2, mitochondrial… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.